RESUMEN
OBJECTIVE: This study assessed the long-term effects of triple therapy with prostanoids on patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD), as there is limited information on the safety and efficacy of this treatment approach. METHODS: A retrospective cohort study was conducted on patients with PAH-CHD who were actively followed up at our centre. All patients were already receiving dual combination therapy at maximum doses. Clinical characteristics, including functional class (FC), 6-minute walking test distance (6MWTD) and N-terminal pro-brain natriuretic peptide (NT-proBNP) levels, were documented before initiating triple therapy and annually for a 2-year follow-up period. RESULTS: A total of 60 patients were included in the study, with a median age of 41 years and 68% being women. Of these, 32 had Eisenmenger syndrome, 9 had coincidental shunts, 18 had postoperative PAH and 1 had a significant left-to-right shunt. After 1 year of triple combination initiation, a significant improvement in 6MWTD was observed (406 vs 450; p=0.0027), which was maintained at the 2-year follow-up. FC improved in 79% of patients at 1 year and remained stable in 76% at 2 years. NT-proBNP levels decreased significantly by 2 years, with an average reduction of 199 ng/L. Side effects were experienced by 33.3% of patients but were mostly mild and manageable. Subgroup analysis showed greater benefits in patients without Eisenmenger syndrome and those with pre-tricuspid defects. CONCLUSIONS: Triple therapy with prostanoids is safe and effective for patients with PAH-CHD, improving FC, 6MWTD and NT-proBNP levels over 2 years. The treatment is particularly beneficial for patients with pre-tricuspid defects and non-Eisenmenger PAH-CHD.
Asunto(s)
Complejo de Eisenmenger , Cardiopatías Congénitas , Hipertensión Pulmonar , Hipertensión Arterial Pulmonar , Humanos , Femenino , Adulto , Masculino , Hipertensión Arterial Pulmonar/diagnóstico , Hipertensión Arterial Pulmonar/tratamiento farmacológico , Hipertensión Arterial Pulmonar/etiología , Complejo de Eisenmenger/complicaciones , Complejo de Eisenmenger/tratamiento farmacológico , Hipertensión Pulmonar/diagnóstico , Hipertensión Pulmonar/tratamiento farmacológico , Hipertensión Pulmonar/etiología , Vasodilatadores/uso terapéutico , Estudios Retrospectivos , Cardiopatías Congénitas/complicaciones , Hipertensión Pulmonar Primaria Familiar/complicaciones , Prostaglandinas/uso terapéuticoRESUMEN
This study aimed to evaluate the feasibility of a noninvasive operability assessment of chronic thromboembolic pulmonary hypertension (CTEPH) based on multidetector computed tomographic angiography (MCTA). Up to 176 patients were evaluated from January 2016 to April 2018. Throughout the first phase, the initial surgical decision was made based on MCTA with further analysis of pulmonary angiography (PA) in order to evaluate in which cases the initial decision was not modified by PA. During the second phase, PA was limited to patients judged inoperable based on MCTA or those whose assessment was not possible. Patients deemed operable (50%) based on MCTA along the first phase had been adequately classified, as PA did not modify the initial decision in all but one patient. Comparable results were obtained throughout the implementation phase. Regarding operated patients, the decision of operability was based solely on MCTA in 94% of those with level I disease, in 75% with level II, and 54% with level III. This approach enabled shorter periods of time to complete surgical assessment and the avoidance of PA-related morbidity. Baseline parameters, postoperative measures, and survival rates at 1 year after surgery were comparable in both phases. Noninvasive operability assessment is feasible in a subset of CTEPH patients and optimizes surgical candidacy evaluation.
RESUMEN
OBJECTIVE: The aim of this study is to identify foot health factors related to the quality of life in patients with rheumatoid arthritis (RA). SETTING: In this cross-sectional study, a total of 293 subjects were analysed, 229 of whom were in the RA group and 64 in the control group. In the RA group, 173 patients were female, and 50 in the control group. PARTICIPANTS: Patients with foot pain and RA (according to the American College of Rheumatology/European League Against Rheumatism 2010 rheumatoid arthritis classification criteria) and with foot pain but no RA were recruited (Granada, Spain). INTERVENTION: Two researchers independently interviewed the patients to obtain data for the study. PRIMARY AND SECONDARY OUTCOME MEASURES: Clinical data were obtained using the Short Form 12-Item questionnaire (quality of life) (primary outcome), Visual Analogue Scale for pain (VAS pain), the Manchester Foot Pain Disability Index (MFPDI) and the Foot Function Index (FFI). Anthropometric measurements were obtained using a foot measurement platform, the Foot Posture Index and the Manchester Scale of Hallux Valgus (secondary outcomes). RESULTS: Of the 293 subjects, 76.1% were female. Significant differences were observed between the RA and the control group (p<0.001) with regard to VAS pain (general, foot and hand), MFPDI and FFI. In terms of anthropometric measurements, significant differences were only recorded for midfoot and forefoot width (p=0.03). For the physical health component, multivariable linear regression with the parameters age, gender, VAS pain (general) and the presence of RA presented an R2 value of 48.8%, while for the mental health component the corresponding value was 5.6%. CONCLUSION: Morphological and structural characteristics of the foot are not necessarily associated with pain, disability and loss of function. The presence of RA, a higher score on VAS pain (general), female gender and older age are all associated with the physical component of the quality of life of patients with RA.
Asunto(s)
Artritis Reumatoide , Calidad de Vida , Anciano , Artritis Reumatoide/complicaciones , Estudios Transversales , Femenino , Humanos , Masculino , España , Encuestas y CuestionariosRESUMEN
Se precisa conocer la percepción de los profesionales de enfermería acerca de la atención emocional y espiritual prestada en el plan de cuidados del paciente. El objetivo fue conocer la atención espiritual que brindan las enfermeras y enfermeros en su trabajo diario durante el pro ceso de estancia hospitalaria de un paciente así como detectar posibles factores asociados que afloran al enfrentarse a la muerte. Material y Métodos. La unidad de análisis son los estudios originales primarios. Se hicieron búsquedas electrónicas (Cuiden, Scielo, Pubmed) y manuales de artículos relevantes recientemente publicados en revistas, bibliografías y listas de referencias de revisiones y documentos. Resultados y Conclusiones. Existen una serie de factores que dificultan la adecuada intervención del profesional de enfermería en situaciones concretas de no salud: principalmente cuando el paciente siente la necesidad imperiosa de obtener información sobre su estado de salud porque se encuentra ingresado en un centro hospitalario en situaciones terminales, así como también cuando le comunican de repente que tiene un grave trastorno orgánico en alguna estructura corporal y con algún grado de limitación que le impide una actividad física habitual de repente como consecuencia de ello se enfrenta a emociones como la angustia, el miedo, la depresión, la rabia, la insatisfacción, etc que son emociones con alta carga emocional y espiritual (AU)
It is necessary to know the perception of nurses about the emotional attention given to patients at the spiritual dimension in patient care plan. The objective was to know the spiritual care offered by nurses in their daily work during a patients hospital stay and detect possible associated factors that hinder the facing death. Material and Methods. The unit of analysis has been the primary original studies, electronic searches (Cuiden, Scielo, Pubmed) and manuals relevant of articles published in journals, bibliographies and reference lists of reviews and papers were made. Results and Conclusions. There are a number of factors that hinder the proper intervention of nursing professionals in specific situations of non-health: especially when the patient feels the urgent need to obtain information on their health status because it is admitted in a hospital in terminal situation, as when you communicate suddenly having a serious organic disorder in some body structure with some degree of limitation prevents regular physical activity . as a result he feels emotions like anxiety, fear, depression, anger, dissatisfaction, etc which are emotions with high emotional and spiritual burden (AU)
É necessário conhecer a percepção dos enfermeiros sobre o cuidado emocional e espiritual previsto no plano de cuidados do paciente. O objetivo foi conhecer a assistência espiritual oferecida por enfermeiros no seu trabalho diário durante a internação do paciente e detectar possíveis fatores associados que surgem quando enfrentar a morte. Material e Métodos. A unidade de análise é os estudos originais primários. buscas eletrônicas (CUIDEN, SciELO, PubMed) e manuais de artigos relevantes publicados recentemente em revistas, bibliografias e listas de referência de comentários e papéis foram feitas. Resultados e conclusões. Há uma série de fatores que dificultam a intervenção adequada dos profissionais de enfermagem em situações específicas de não-saúde: especialmente quando o paciente sente-se a necessidade urgente de obter informações sobre o seu estado de saúde, porque é admitido em um hospital em situações terminais, como quando você se comunica de repente tem uma doença orgânica grave em alguma estrutura do corpo com algum grau de limitação impede que a atividade física regular, de repente ... como resultado enfrenta emoções, como ansiedade, medo, depressão , raiva, insatisfação, etc, que são emoções com alta carga emocional e espiritual (AU)
Asunto(s)
Humanos , Personal de Enfermería/organización & administración , Personal de Enfermería/psicología , Atención de Enfermería/organización & administración , Atención de Enfermería/normas , Terapias Espirituales/enfermería , Atención de Enfermería/psicología , Tiempo de Internación/tendencias , Cuidado Terminal , Enfermería de Cuidados Paliativos al Final de la Vida/historia , Enfermería de Cuidados Paliativos al Final de la Vida/organización & administraciónRESUMEN
Fundamento y objetivo: La cirugía de tromboendarterectomía pulmonar es el tratamiento de elección para la hipertensión pulmonar tromboembólica crónica; un factor de riesgo para la mortalidad hospitalaria son las resistencias vasculares pulmonares muy elevadas. El objetivo de este trabajo fue analizar los resultados inmediatos y a largo plazo de la cirugía para la hipertensión pulmonar tromboembólica crónica en pacientes con hipertensión pulmonar muy grave. Material y métodos: Desde febrero de 1996 hemos realizado 160 tromboendarterectomías pulmonares. Dividimos esta población en grupo 1 -40 pacientes con resistencias vasculares pulmonares ≥ 1.090dinas/s/cm-5- y grupo 2 -los 120 restantes-. Resultados: La mortalidad hospitalaria (15 frente a 2,5%), el edema pulmonar de reperfusión (33 frente a 14%) y la insuficiencia cardiaca (23 frente a 3,3%) fueron significativamente mayores en el grupo 1; pero al año, no hay diferencia en la situación clínica, hemodinámica y ecocardiográfica con el grupo 2. La supervivencia a los 5 años fue del 77% en el grupo 1 y del 92% en el grupo 2 (p=0,033). Excluyendo los primeros 46 enfermos, considerados curva de aprendizaje, no hubo diferencia en la mortalidad hospitalaria (3,8 frente a 2,3%) ni en la supervivencia (96,2% en el grupo 1 y 96,2% en el grupo 2 a los 5 años). Conclusiones: La tromboendarterectomía pulmonar tiene una morbimortalidad inicial mayor en pacientes con hipertensión pulmonar tromboembólica crónica muy grave, pero obtiene el mismo beneficio a medio-largo plazo. En nuestra experiencia, tras la curva de aprendizaje, la cirugía ofrece la misma seguridad y excelentes resultados a los pacientes más graves, y ninguna cifra de resistencias vasculares pulmonares debería ser considerada una contraindicación absoluta (AU)
Background and objective: Pulmonary thromboendarterectomy surgery is the treatment of choice for patients with chronic thromboembolic pulmonary hypertension; extremely high pulmonary vascular resistance constitutes a risk factor for hospital mortality. The objective of this study was to analyze the immediate and long-term results of the surgical treatment of chronic thromboembolic pulmonary hypertension in patients with very severe pulmonary hypertension. Material and methods: Since February 1996, we performed 160 pulmonary thromboendarterectomies. We divided the patient population in 2 groups: group 1, which included 40 patients with pulmonary vascular resistance≥1090dyn/sec/cm-5, and group 2, which included the remaining 120 patients. Results: Hospital mortality (15 vs. 2.5%), reperfusion pulmonary edema (33 vs. 14%) and heart failure (23 vs. 3.3%) were all higher in group 1; however, after one year of follow-up, there were no significant differences in the clinical, hemodynamic and echocardiographic conditions of both groups. Survival rate after 5 years was 77% in group 1 and 92% in group 2 (P=.033). After the learning curve including the 46 first patients, there was no difference in hospital mortality (3.8 vs. 2.3%) or survival rate after 5 years (96.2% in group 1 and 96.2% in group 2). Conclusions: Pulmonary thromboendarterectomy is linked to significantly higher morbidity and mortality rates in patients with severe chronic thromboembolic pulmonary hypertension. Nevertheless, these patients benefit the same from the procedure in the mid-/long-term. In our experience, after the learning curve, this surgery is safe in severe pulmonary hypertension and no level of pulmonary vascular resistance should be an absolute counter-indication for this surgery (AU)
Asunto(s)
Humanos , Endarterectomía , Hipertensión Pulmonar/complicaciones , Embolia Pulmonar/cirugía , Resultado del Tratamiento , Enfermedad Crónica , Resistencia Vascular/fisiología , Indicadores de Morbimortalidad , Seguridad del PacienteRESUMEN
BACKGROUND AND OBJECTIVE: Pulmonary thromboendarterectomy surgery is the treatment of choice for patients with chronic thromboembolic pulmonary hypertension; extremely high pulmonary vascular resistance constitutes a risk factor for hospital mortality. The objective of this study was to analyze the immediate and long-term results of the surgical treatment of chronic thromboembolic pulmonary hypertension in patients with very severe pulmonary hypertension. MATERIAL AND METHODS: Since February 1996, we performed 160 pulmonary thromboendarterectomies. We divided the patient population in 2 groups: group 1, which included 40 patients with pulmonary vascular resistance≥1090dyn/sec/cm-5, and group 2, which included the remaining 120 patients. RESULTS: Hospital mortality (15 vs. 2.5%), reperfusion pulmonary edema (33 vs. 14%) and heart failure (23 vs. 3.3%) were all higher in group 1; however, after one year of follow-up, there were no significant differences in the clinical, hemodynamic and echocardiographic conditions of both groups. Survival rate after 5 years was 77% in group 1 and 92% in group 2 (P=.033). After the learning curve including the 46 first patients, there was no difference in hospital mortality (3.8 vs. 2.3%) or survival rate after 5 years (96.2% in group 1 and 96.2% in group 2). CONCLUSIONS: Pulmonary thromboendarterectomy is linked to significantly higher morbidity and mortality rates in patients with severe chronic thromboembolic pulmonary hypertension. Nevertheless, these patients benefit the same from the procedure in the mid-/long-term. In our experience, after the learning curve, this surgery is safe in severe pulmonary hypertension and no level of pulmonary vascular resistance should be an absolute counter-indication for this surgery.
Asunto(s)
Endarterectomía , Hipertensión Pulmonar/cirugía , Embolia Pulmonar/cirugía , Anciano , Enfermedad Crónica , Femenino , Estudios de Seguimiento , Mortalidad Hospitalaria , Humanos , Hipertensión Pulmonar/etiología , Hipertensión Pulmonar/mortalidad , Estimación de Kaplan-Meier , Modelos Logísticos , Masculino , Persona de Mediana Edad , Embolia Pulmonar/complicaciones , Embolia Pulmonar/mortalidad , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , Tasa de Supervivencia , Resultado del TratamientoRESUMEN
Introducción: La tromboendarterectomía pulmonar es el tratamiento de elección en la hipertensión pulmonar tromboembólica crónica. Presentamos nuestra serie completa con esta técnica. Métodos: Desde febrero de 1996 hasta junio de 2014, hemos realizado 106 tromboendarterectomías. Analizamos las características de la población, la mortalidad y morbilidad asociadas a la técnica y los resultados a largo plazo de supervivencia, mejoría funcional y resolución de la hipertensión pulmonar. Resultados: La edad media de la población fue 53 ± 14 años. El 89% estaba en clase funcional III-IV de la OMS. La presión pulmonar media prequirúrgica fue 49 ± 13 mmHg y las resistencias vasculares pulmonares 831 ± 364 dinas.s.cm-5. La mortalidad hospitalaria fue 6,6%. La morbilidad postoperatoria más relevante fue debida al edema pulmonar por reperfusión en el 20%, que fue factor de riesgo independiente (p = 0,015) para mortalidad hospitalaria. Con una mediana de seguimiento de 31 meses (rango intercuartil 50), la supervivencia a los 3 y 5 años es 90 y 84%. Al año de seguimiento, el 91% está en clase funcional I-II de la OMS, la presión pulmonar media en 27 ± 11 mmHg y las resistencias pulmonares vasculares en 275 ± 218 dinas.s.cm-5 (significativamente menores (p < 0,05) que las basales). En 14 pacientes se diagnosticó hipertensión pulmonar persistente; aun así, su supervivencia es, a los 3 y 5 años, 91 y 73%, respectivamente. Conclusiones: La tromboendarterectomía pulmonar ofrece resultados excelentes en el tratamiento de la hipertensión pulmonar tromboembólica crónica. Proporciona una elevada supervivencia a largo plazo, mejora la capacidad funcional y resuelve la hipertensión pulmonar en la mayoría de los pacientes
Introduction: Pulmonary thromboendarterectomy is the treatment of choice in chronic thromboembolic pulmonary hypertension. We report our experience with this technique. Methods: Between February 1996 and June 2014, we performed 106 pulmonary thromboendarterectomies. Patient population, morbidity and mortality and the long-term results of this technique (survival, functional improvement and resolution of pulmonary hypertension) are described. Results: Subjects' mean age was 53 ± 14 years. A total of 89% were WHO functional class IIIIV, presurgery mean pulmonary pressure was 49 ± 13 mmHg and mean pulmonary vascular resistance was 831 ± 364 dynes s cm-5. In-hospital mortality was 6.6%. The most important post-operative morbidity was reperfusion pulmonary injury, in 20% of patients; this was an independent risk factor (P = .015) for hospital mortality. With a 31-month median follow-up (interquartile range: 50), 3- and 5-year survival was 90% and 84% respectively. At 1 year, 91% were WHO functional class III; mean pulmonary pressure (27 ± 11 mmHg) and pulmonary vascular resistance (275 ± 218 dynes s cm-5) were significantly lower (P < .05) than before the intervention. Although residual pulmonary hypertension was detected in 14 patients, their survival at 3 and 5 years was 91% and 73%, respectively. Conclusions: Pulmonary thromboendarterectomy offers excellent results in chronic thromboembolic pulmonary hypertension. Long-term survival is good, functional capacity improves, and pulmonary hypertension is resolved in most patients
Asunto(s)
Femenino , Humanos , Masculino , Persona de Mediana Edad , Endarterectomía/instrumentación , Endarterectomía/métodos , Endarterectomía , Hipertensión Pulmonar/complicaciones , Hipertensión Pulmonar/cirugía , Hipertensión Pulmonar , Embolia Pulmonar/complicaciones , Embolia Pulmonar/cirugía , Indicadores de Morbimortalidad , Supervivencia/fisiología , Mortalidad Hospitalaria/tendencias , Complicaciones Posoperatorias/diagnóstico , Complicaciones Posoperatorias/fisiopatología , Relación Ventilacion-Perfusión/fisiología , Esternotomía , Estudios de Seguimiento , Intervalos de ConfianzaRESUMEN
INTRODUCTION: Pulmonary thromboendarterectomy is the treatment of choice in chronic thromboembolic pulmonary hypertension. We report our experience with this technique. METHODS: Between February 1996 and June 2014, we performed 106 pulmonary thromboendarterectomies. Patient population, morbidity and mortality and the long-term results of this technique (survival, functional improvement and resolution of pulmonary hypertension) are described. RESULTS: Subjects' mean age was 53±14 years. A total of 89% were WHO functional class III-IV, presurgery mean pulmonary pressure was 49±13mmHg and mean pulmonary vascular resistance was 831±364 dynes.s.cm(-5). In-hospital mortality was 6.6%. The most important post-operative morbidity was reperfusion pulmonary injury, in 20% of patients; this was an independent risk factor (p=0.015) for hospital mortality. With a 31-month median follow-up (interquartile range: 50), 3- and 5-year survival was 90 and 84%. At 1 year, 91% were WHO functional class I-II; mean pulmonary pressure (27±11mmHg) and pulmonary vascular resistance (275±218 dynes.s.cm(-5)) were significantly lower (p<0.05) than before the intervention. Although residual pulmonary hypertension was detected in 14 patients, their survival at 3 and 5 years was 91 and 73%, respectively. CONCLUSIONS: Pulmonary thromboendarterectomy offers excellent results in chronic thromboembolic pulmonary hypertension. Long-term survival is good, functional capacity improves, and pulmonary hypertension is resolved in most patients.
Asunto(s)
Endarterectomía/métodos , Hipertensión Pulmonar/etiología , Embolia Pulmonar/cirugía , Trombectomía/métodos , Adulto , Anciano , Puente Cardiopulmonar , Enfermedad Crónica , Endarterectomía/estadística & datos numéricos , Femenino , Estudios de Seguimiento , Mortalidad Hospitalaria , Humanos , Hipotermia Inducida , Hipoxia/etiología , Hipoxia/terapia , Estimación de Kaplan-Meier , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/etiología , Complicaciones Posoperatorias/mortalidad , Complicaciones Posoperatorias/terapia , Embolia Pulmonar/complicaciones , Recuperación de la Función , Daño por Reperfusión/etiología , Daño por Reperfusión/terapia , Respiración Artificial , Trombectomía/estadística & datos numéricos , Resultado del Tratamiento , Resistencia Vascular , Adulto JovenRESUMEN
No disponible